TABLE 7.
HAI and NAI-antibody titers of the first and second serum sample in the five individuals who met the seroconversion criteria from the summer cohort
| Antigena | Sera | Individual |
||||
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | ||
| IAV_H1 | First | 40 | 5 | 5 | 10 | 5 |
| Second | 40 | 5 | 20 | 10 | 5 | |
| IAV_H3 | First | 10 | 10 | 5 | 5 | 10 |
| Second | 40 | 10 | 40 | 5 | 40 | |
| IAV_N1 | First | 80 | 20 | 320 | 10 | 320 |
| Second | 160 | 80 | 320 | 80 | 320 | |
| IAV_N2 | First | 40 | 10 | 40 | 10 | 20 |
| Second | 40 | 80 | 40 | 40 | 40 | |
| IBV (Victoria)_HA | First | 5 | 80 | 5 | 5 | 5 |
| Second | 5 | 80 | 5 | 5 | 5 | |
| IBV (Victoria)_NA | First | 640 | 2,560 | 40 | 320 | 640 |
| Second | 640 | 2,560 | 160 | 320 | 640 | |
| IBV (Yamagata)_HA | First | 5 | 80 | 5 | 5 | 40 |
| Second | 5 | 80 | 5 | 5 | 40 | |
| IBV (Yamagata)_NA | First | 640 | 2,560 | 40 | 320 | 320 |
| Second | 640 | 2,560 | 160 | 320 | 2,560 | |
a
IAV, influenza A virus; IBV, influenza B virus. Seroconversion events are indicated in boldface.